. Here we identify IL-35-producing B cells as key players in the negative regulation of immunity. Mice in which only B cells did not express IL-35 lost their ability to recover from the T-cellmediated demyelinating autoimmune disease experimental autoimmune encephalomyelitis (EAE). In contrast, these mice displayed a markedly improved resistance to infection with the intracellular bacterial pathogen Salmonella enterica serovar Typhimurium as shown by their superior containment of the bacterial growth and their prolonged survival after primary infection, and upon secondary challenge, compared to control mice. The increased immunity found in mice lacking IL-35 production by B cells was associated with a higher activation of macrophages and inflammatory T cells, as well as an increased function of B cells as antigen-presenting cells (APCs). During Salmonella infection, IL-35-and IL-10-producing B cells corresponded to two largely distinct sets of surface-IgM int plasma cells expressing the transcription factor Blimp1 (also known as Prdm1). During EAE, CD138
1 plasma cells were also the main source of B-cell-derived IL-35 and IL-10. Collectively, our data show the importance of IL-35-producing B cells in regulation of immunity and highlight IL-35 production by B cells as a potential therapeutic target for autoimmune and infectious diseases. This study reveals the central role of activated B cells, particularly plasma cells, and their production of cytokines in the regulation of immune responses in health and disease.
The inhibitory activities of B cells involve their production of IL-10, which in mice can protect from autoimmunity but impair resistance to infection [3] [4] [5] [6] . Such suppressive function could be relevant to human diseases. A defect in IL-10 secretion by B cells was observed in patients with multiple sclerosis and type 1 diabetes 7, 8 . Furthermore, B-cell depletion therapy had deleterious effects in some patients with multiple sclerosis or ulcerative colitis 9, 10 , and led to ulcerative colitis or psoriasis in patients with Graves' disease or rheumatoid arthritis, respectively 11, 12 . These effects were probably not all owing to a loss of IL-10-producing B cells. Mouse B cells could inhibit immunity independently of 14) . However, no mediator to account for this has been characterized. There is an urgent need to identify additional factors mediating regulatory functions of B cells.
B cells require activation to exert suppressive activity and Toll-like receptors (TLR) are critical in this process. Mice with deficiencies in both TLR2 and TLR4 restricted to B cells developed an exacerbated EAE after immunization with the encephalitogenic peptide from myelin oligodendrocyte glycoprotein ) 15 . Using mice with single deficiencies in these TLR restricted to B cells (B Tlr2 2/2 and B Tlr4 2/2 mice, respectively), we found that TLR4 was the most critical for B-cellmediated suppression in EAE (Fig. 1a and Extended Data Fig. 1a) .
With our previous studies 3 , these results establish TLR4 and CD40 as receptors essential for the regulatory function of B cells in EAE. CD40 also contributes to the protective roles of B cells in ulcerative colitis and arthritis 4, 5 . IL-10 production by B cells is required for recovery from EAE 3 . Naive B cells produced IL-10 after TLR4 engagement, but not upon co-stimulation by TLR4 plus CD40 (Fig. 1b and Extended Data Fig. 1b) . To identify additional suppressive factor(s) produced upon TLR4 plus CD40 stimulation, we performed Affymetrix array analyses on (1) naive B cells, (2) B cells activated by TLR4 and (3) B cells activated by TLR4 plus CD40, and focused on genes coding for secreted molecules (Extended Data Fig. 1c ). Among the genes differentially expressed, of interest was Epstein-Barr virus-induced gene 3 (Ebi3), a member of the IL-12 cytokine family that can dimerize with p28 or p35 to generate IL-27 or IL-35, respectively, which both have suppressive functions [16] [17] [18] [19] . B cells did not express p40 (also known as Il12b) messenger RNA, highlighting its celltype specific expression pattern 20 , but constitutively transcribed p35 (also known as Il12a) (Extended Data Fig. 1d ). In fact, B cells were the main source of p35 mRNA in secondary lymphoid tissues (Fig. 1d) . B cells upregulated expression of p35 and Ebi3 mRNA, as well as EBI3 protein upon activation by TLR4 plus CD40, which was further increased upon B-cell receptor for antigen (BCR) engagement, suggesting they could secrete IL-35 ( Fig. 1e and Extended Data Fig. 1 ). This was confirmed by co-immunoprecipitation using supernatants from TLR4 plus CD40-activated B cells (Fig. 1f) . We conclude that B cells can secrete IL-35 after activation by TLR4 plus CD40.
To evaluate the role of IL-35 expression by B cells during EAE, we used mice with a B-cell-restricted deficiency in p35 (B 
. We also used mice in which B cells could not express p40 (B p40 2/2 ), or p28 (B p28 2/2 ), because p35 can dimerize with p40 to form IL-12, and EBI3 can associate with p28 to form IL-27. B cells secreted p28 after activation (Extended Data Fig. 1j ). B p35 2/2 and B Ebi3 2/2 mice developed exacerbated EAE, whereas B p40 2/2 and B p28 2/2 mice had disease courses similar to B WT controls (Fig. 2a and Extended Data Fig. 2) . Therefore, B cells limited EAE pathogenesis through provision of IL-35. EAE pathogenesis involves T H 1 and T H 17 cells, which express IFN-c and IL-17, respectively 21, 22 . B p35 2/2 mice displayed increased MOG-reactive IFN-c and IL-17 production compared to control mice ( Fig. 2b and Extended Data Fig. 2d ). In contrast, B p28 2/2 and B p40 2/2 mice mounted normal T-cell responses ( Fig. 2b and Extended Data Fig. 2) . B p35 2/2 mice had more CD4
1 T cells and mononuclear phagocytes in the central nervous system than B WT mice (Extended Data Fig. 2 ), suggesting that B-cell-derived IL-35 limited disease by reducing the accumulation of pathogenic cells in the target organ. These data demonstrate that B-cellderived IL-35 is a critical regulator of T-cell-mediated autoimmunity.
The mechanisms underlying the suppressive activities of IL-35 remain poorly understood 23 . During EAE, the increased T-cell response observed in B p35 2/2 mice was not due to a defect in CD4 1 Foxp3 1 T regulatory (Treg) cells (Extended Data Fig. 2 ), which are protective in this disease 24 . B cells from B p35 2/2 mice expressed higher levels of activation markers (CD44, CD69) and molecules involved in antigen presentation to CD4 1 T cells (MHC-II, CD80, CD86), compared to control B cells (Extended Data Fig. 3 ). Accordingly, they were more potent APC, stimulating higher proliferation and production of inflammatory cytokines (IL-17 and GM-CSF) by MOG-reactive CD4
1 T cells than control B cells (Fig. 2c, d and Extended Data Fig. 3c ). Preliminary studies showed that B p35 2/2 mice were susceptible to EAE induced with human MOG, a a, EAE was induced in B Tlr2 2/2 (grey squares, n 5 8), B Tlr4 2/2 (black triangles, n 5 8) and B WT mice (grey circles, n 5 16). Data show clinical EAE scores from two independent experiments (mean 6 s.e.m.). Cumulative disease scores were compared using two-tailed unpaired t-test. b, Splenic B cells from IL-10-eGFP (knock-in of eGFP at Il10 locus) mice were stimulated for 72 h with LPS (1 mg ml 21 ) or LPS (1 mg ml
21
) plus anti-CD40 (10 mg ml 21 ), and eGFP expression was measured by flow cytometry. Plots show eGFP expression by live CD19 1 cells. Results are representative of three independent experiments. c, Hierarchical cluster analysis of secreted factors differentially expressed between B cells activated with LPS or LPS plus anti-CD40 (Pearson correlation with average linkage). Affymetrix microarrays were performed in quadruplicates. Gene expression levels are shown for each array compared to its average value for all arrays, within a scale from twofold increase (yellow) to twofold decrease (blue). d, p35 mRNA expression was quantified by RT-PCR in lymph nodes and spleen from naive C57BL/6 and B-cell-deficient JHT mice, as well as in B cells purified from lymph nodes and spleen of C57BL/6 mice. Data show compilation of three independent experiments (mean 6 s.e.m.). e, Splenic B cells were activated as indicated for 72 h, and treated with GolgiStop for the last 4 h of culture. B-cell lysates were separated on SDS-PAGE gel and blotted with anti-EBI3 or anti-actin antibody. Data shows a representative result from three independent experiments. f, B cells from C57BL/6 or p35-deficient mice were activated for 72 h with LPS plus anti-CD40. Culture supernatants were subjected to immunoprecipitation with anti-p35 followed by western blot with anti-EBI3 antibody. Data shown are representative of two independent experiments. mice displayed longer survival than B p40 2/2 and B WT mice after primary infection, and upon secondary challenge (Fig. 3a) . This improved resistance correlated with better control of the bacterial burden in spleen and liver, increased accumulation of macrophages in these organs, and stronger inflammatory T-cell responses towards Salmonella (Fig. 3b, c and Extended Data Fig. 4 ). In contrast, B-cell-derived IL-35 had no effect on Treg frequencies, global frequencies of activated T cells or humoral immunity against Salmonella (Extended Data Figs 4 and 5a) . B p35 2/2 mice also mounted normal antibody responses against a haptenprotein antigen (Extended Data Fig. 5b) . Consistent with the role of CD40 in IL-35 production by B cells (Fig. 1 ), mice with a B-cell-restricted deficiency in CD40 displayed enhanced control of Salmonella infection (Extended Data Fig. 5c ). These data demonstrate that B cells can inhibit anti-microbial immunity through production of IL-35.
B cells can also inhibit anti-Salmonella immunity through ). To identify IL-10-and IL-35-producing B cells, and clarify their relationship, we quantified Ebi3 and Il10 mRNA in CD19
1

CD138
2 B cells and CD138
hi plasma cells during Salmonella infection ( Fig. 4a and Extended Data Fig. 6 ). Ebi3 and Il10 were exclusively induced in CD138 hi cells (Fig. 4a ). Single-cell PCR analyses indicated that distinct sets of CD138 hi cells expressed the mRNA for Il10 or for both IL-35 subunits Ebi3 and p35 (Fig. 4b) . We therefore characterized further these plasma cells. They expressed uniform surface levels of IgM, CD80, CD86, MHC-II, CD40, CD69, CD44, CD43, TACI and CXCR4, as well as intermediate levels of CD1d (also known as Cd1d1) and Tim1 (also known as Havcr1) (Extended Data Fig. 6a, d Fig. 7 ). These subsets differed by their capacity to produce antibodies, and expressed distinct amounts of mRNA for the transcription factors driving plasma cell development (Blimp1, IRF4), or maintaining B-cell identity (Pax5) (Extended Data Fig. 7 ), demonstrating that they corresponded to different stages of plasma cell development. The expression levels of Il10 and Ebi3 mRNA in these subsets correlated with their degree of maturity, and were highest in the most differentiated CD138 hi CD22 2 cells (Extended Data Fig. 7c ). CD138 hi CD22
2 plasma cells were mostly located at the interface between red and white pulp in spleen, in clusters also containing T cells, CD11b 1 and CD169 1 myeloid cells (Extended Data Fig. 7d ). Single-cell PCR analyses revealed that 6-10% of CD138 hi cells expressed Il10 mRNA, and a similar frequency made mRNA for both IL-35 subunits, whereas few cells co-expressed these three transcripts together (Fig. 4b) . Nearly all CD138 hi cells transcribing Il10 or both IL-35 subunits co-expressed Blimp1 (Fig. 4c) , as expected for plasma cells. The less mature CD138 int CD22
1 population contained little Il10 or Ebi3 mRNA (Extended Data Fig. 7c ), and only rare cells contained Il10 mRNA (Fig. 4b) , suggesting that expression of IL-10 and both IL-35 subunits were acquired during plasma cell maturation. These data indicate that distinct sets of plasma cells provide IL-10 and IL-35 during Salmonella infection.
Plasma cells from mice infected with Salmonella consistently secreted more IL-10 than B cells upon ex vivo stimulation ( Fig. 4d and Extended Data Fig. 8 ). Around 70% of CD138 hi plasma cells upregulated IL-10 expression after stimulation with phorbol 12-myristate 13-acetate plus ionomycin, a classical treatment for identifying cytokine-producing cells (Extended Data Fig. 8 ). CD138
1 plasma cells were also the major B-cell subtype expressing the proteins EBI3 and p35 (Fig. 4e) Ebi3 2/2 (n 5 12) and corresponding B WT mice (n 5 13), B p40 2/2 (n 5 13) and corresponding B WT mice (n 5 14) after infection with virulent Salmonella (SL1344). Data pooled from two independent experiments. Survival curves were compared using Wilcoxon test. Bottom panel shows survival curves of B p35 2/2 (n 5 15) and corresponding B WT mice (n 5 16), B Ebi3 2/2 (n 5 15) and corresponding B WT mice (n 5 15), B p40 2/2 (n 5 11) and corresponding B WT mice (n 5 14) vaccinated with attenuated Salmonella (SL7207) and 90 days later re-challenged with virulent Salmonella (SL1344). Data are pooled from two independent experiments. Survival curves were compared using Wilcoxon test. b, Representative FACS plot of mononuclear phagocytes (MP) gated as CD11b (n 5 6) and B WT (n 5 8), B Ebi3 2/2 (n 5 7) and B WT (n 5 5), B p40 2/2 (n 5 8) and B WT (n 5 8). Data are pooled from two independent experiments. Graphs show mean 6 s.e.m. c, Mice were infected with attenuated Salmonella (SL7207). After 21 days, bone marrow cells were stained for CD4 and CD40L or IFN-c after 6 h re-stimulation with heat-killed Salmonella. Representative FACS plots of IFN-c 1 cells among CD4 1 T cells from B WT and B p35 2/2 mice (left panel). Frequencies of IFN-c 1 and CD40L 1 cells among CD4 1 T cells, (middle and right panels, respectively). Data are pooled from two independent experiments with total number of mice: B p35 2/2 (n 5 12) and corresponding B WT (n 5 10), B Ebi3 2/2 (n 5 8) and corresponding B WT (n 5 9), B p40 2/2 (n 5 15) and corresponding B WT (n 5 9). b, c, Data were analysed using two-tailed unpaired t-test with Welch's correction in case of unequal variance. P values .0.05 are considered not significant (NS).
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infection, emphasizing the regulatory potential of plasma cells compared to other B cell subsets.
Our study identifies IL-35-producing B cells as critical regulators of immunity. At a time window during Salmonella infection when both B-cell-derived IL-10 (ref. 6) and IL-35 exerted suppressive functions, plasma cells were the major B-cell type expressing these cytokines. This was also the case during EAE (Extended Data Fig. 9 ). During Salmonella infection, IL-10 and IL-35 were made by distinct sets of plasma cells, suggesting that these two suppressive axes can operate in parallel. In line with this, mice in which individual B cells could express either IL-10 or IL-35, but not both cytokines, displayed a normal EAE course (Extended Data Fig. 9 ). Accordingly, B and plasma cells could produce IL-10 without concomitant IL-35 secretion (Extended Data Fig. 9 ). Future studies shall assess whether 'regulatory plasma cells' producing IL-10 and IL-35 (but not IL-6) can provide novel opportunities for immune intervention.
METHODS SUMMARY
p28 2/2 and B WT mice were generated using a previously described mixed bone marrow chimaera approach 3, 6 , as detailed in the Methods, and outlined in Extended Data Fig. 10 . This protocol allowed normal reconstitution of the B-cell compartment in the resulting chimaera (Extended Data Fig. 10 ). EAE was induced in mice by immunization with MOG 35-55 emulsified in complete Freund's adjuvant (Sigma-Aldrich). The disease score and the MOG 35-55 specific T-cell responses (at days 10 and 28) were assessed as described previously 3 . Mouse B cells were purified and activated as described before 15 . Cytokine secretion was determined by Bio-Plex or ELISA. Whole transcriptome analyses were performed with RNA purified from naive and activated B cells, using GeneChip Mouse Genome 430 2.0 Arrays. For mRNA quantification, total RNA was isolated with TRIzol (AMS Biotechnology) and cDNA was prepared with the Reverse Transcription Kit (Promega). Quantitative RT-PCR was performed with LightCycler FastStart DNA Master SYBR Green I (Roche). Western blots to determine EBI3, p35 and actin expression were performed using anti-EBI3 (rabbit M75 polyclonal Ab), anti-p35 (rabbit EPR5736 polyclonal Ab), and anti-actin (rabbit I-19 polyclonal Ab), respectively. For immunoprecipitation, IL-35 was captured with antip35 antibody (clone C18.2; eBioscience) followed by precipitation using mMACS Protein G microbeads (Miltenyi Biotech). Infections with virulent and attenuated Salmonella (strains SL1344 and SL7207, respectively) were performed as published 6 . Flow cytometry analyses were performed as previously described 6 . Other protocols are described in the Methods.
Online Content Any additional Methods, Extended Data display items and Source Data are available in the online version of the paper; references unique to these sections appear only in the online paper. 
CD138
2 B cells were isolated from spleens of C57BL/6 mice on day 3 after infection with attenuated Salmonella (10 7 c.f.u.). Naive B splenic B cells were isolated from unchallenged C57BL/6 mice. Cells were activated for 24 h with PMA/ionomycin and IL-10 was determined in culture supernatants by Bio-Plex. Data shown is pooled from 5 independent experiments. Results were compared using a two-tailed unpaired t-test. e, Splenic CD19 , B Cd40 2/2 and B Il10 2/2 mice were obtained by a previously described mixed bone marrow chimaera approach using lethally irradiated C57BL/6 or JHT mice as recipients 3, 6 . Briefly, B p35 2/2 mice were obtained by reconstituting recipient mice with a mixture of bone marrow cells from B-cell-deficient JHT mice (80%) and p35-deficient mice (20%). Control B WT chimaera were obtained using a mixture of bone marrow cells from JHT mice (80%) and C57BL/6 mice (20%) for experiments shown in Fig. 1a , Fig. 2a left panel, and Fig. 2a, right panel. For all other experiments (including Fig. 2a middle panel, and Extended Data Fig. 2a), corresponding B WT control chimaera were obtained as outlined in Extended Data Fig. 10 , by reconstituting irradiated mice with a mixture of bone marrow cells from C57BL/6 mice (80%) and from mice deficient in the gene of interest (20%). The various control chimaera are called 'corresponding B
WT mice' throughout the study. EAE was induced by immunization with MOG 35-55 peptide, or recombinant human MOG extracellular domain emulsified in Complete Freund's adjuvant (Sigma-Aldrich) and pertussis toxin (Sigma-Aldrich), and assessed as previously described 3 . Mice with a weight loss .20% were humanely euthanized according to ethical regulations. To measure the MOG-reactive T cell response, 8 3 10 5 splenocytes were stimulated in flatbottomed 96-well plates with different concentrations of MOG 35-55 peptide for 2 days, and culture supernatants were then analysed by ELISA to determine concentrations of IFN-c and IL-17 (coating/detection with clones R4-6A2 and XMG1.2 for IFN-c, and TC11-18H10 and TC11-8H4 for IL-17). Mice were infected intravenously with 100 c.f.u. Salmonella strain SL1344, and 10 6 or 10 7 c.f.u. attenuated Salmonella strain SL7207, and assessed as previously described, including for histological analyses 6 . All experiments were reviewed and approved by appropriate institutional review committees (University of Edinburgh ethical review committee, Comite d'Ethique Midi-Pyrenees, and LAGeSo Berlin), and were conducted in accordance with UK, French and German legislations, in compliance with European community council directive 68/609/EEC guidelines. Mice were of C57BL/6 strain, 6-12-weeks old at the start of experiments, and of male and female genders. EAE experiments and Salmonella infections were performed in a blinded manner, and identities of the mice were revealed upon termination of the experiment. No randomization was used. Estimation of size groups was based on our previous experience with these disease models, without a priori determination by power calculation. B-cell purification and activation. B cells were obtained by magnetic isolation using negative selection with anti-CD11b, anti-CD11c, and anti-CD43 microbeads (Miltenyi Biotec). B cells (.99% pure) were activated as previously described ). Dead cells were eliminated from the 24 h and 72 h activated culture by labelling with propidium iodide (PI), and sorting on FACS Diva (BD Biosciences). Cells were lysed in RLT buffer (Qiagen) and total RNA was extracted using RNeasy Mini Kit (Qiagen). Gene array hybridization and data analysis. cRNA were hybridized on Affymetrix MG 430 2.0 arrays, using standard Affymetrix protocol after quality control with Agilent 2100 Bioanalyzer and quantification with NanoDrop ND-1000 spectrophotometer, as previously described 29 . The significantly differentially regulated genes were detected using a t-test based R-script, with P values adjusted using Benjamini Hochberg procedure. In order to be selected in a comparison of two conditions, each Affymetrix ID had to fulfill the following criteria: (1) be present in at least three of the four arrays for at least one of the two conditions compared, (2) to have a mean signal intensity higher than 50 in at least one of the two conditions, and (3) to show an adjusted P value ,0.01 (t-test) in the comparison of the two conditions. The genes differentially expressed between TLR4-activated and TLR4-activated plus CD40-activated B cells (t-test; P , 0.01), and differentially modulated during B-cell activation (t-test; P , 0.01), were then selected and filtered using the gene ontology resource (http://www.geneontology.org) to focus on secreted molecules (Extended Data Fig. 1c) . Seven genes fulfilled these criteria, among which five were uniquely increased in TLR4 plus CD40-stimulated B cells (Extended Data were lysed with 500 ml RIPA buffer (Thermo Fisher Scientific, USA) supplemented with protease inhibitors (Thermo Fisher Scientific, USA). Cells isolated from mice infected with Salmonella were directly lysed in RIPA buffer containing protease inhibitors. Protein concentrations of lysates were determined using the BCA Protein Assay Kit (Thermo Fisher Scientific, USA). Proteins were separated on a polyacrylamide gel and transferred to a PVDF membrane (Bio-Rad Laboratories, USA) using semi-dry blotting. EBI3, p35 and actin were detected using rabbit anti-EBI3 (M-75 polyclonal IgG, Santa Cruz Biotechnology, USA), rabbit anti-p35 (EPR5736 polyclonal IgG, Abcam, UK), or rabbit anti-actin (I-19 polyclonal Ab, Santa Cruz Biotechnology, USA) primary antibody, and horseradish peroxidase (HRP)-conjugated secondary anti-rabbit antibody (cat. number: 81-6120, Invitrogen, USA; or cat. number: 111-035-144, Jackson ImmunoResearch, USA) with ECL (GE Healthcare, UK) as HRP substrate. The chemiluminescence signal was measured using the Image-Reader LAS-3000 (Fujifilm, Japan). For immunoprecipitation, supernatant from B cells activated with LPS plus anti-CD40 (clone FGK-45, 10 mg ml 21 ) were incubated overnight at 4 uC with 2 mg ml 21 anti-p35 (C18.2, eBioscience). Immunoprecipitation was performed using mMACS Protein G Microbeads (Miltenyi Biotech), followed by immunoblot to detect EBI3. B-T cell co-cultures. The protocol for B-T cell co-cultures was adapted from a previous report 25 . Briefly, B cells were magnetically sorted from pooled spleens and lymph nodes of B IL-10-eGFP mice on day 3 after infection with 10 7 colony forming units (c.f.u.) Salmonella (SL7207) by magnetic isolation using anti-CD138-PE (clone 281-2, BD Pharmingen) and anti-PE microbeads (Miltenyi Biotec). The negative fraction was then subjected to FACS sorting to obtain high purity CD19 hi and CD138 int cells were isolated as CD138 1 plasma cells from infected mice by magnetic isolation using anti-CD138-PE (clone 281-2, BD Pharmingen) and anti-PE microbeads (Miltenyi Biotec). Single-cell PCR analysis. Single cells were sorted on a FACS Aria II (BD Biosciences) into a 96-well PCR plate, immediately frozen in liquid nitrogen and stored at 280 uC until further use. For detection of respective transcripts a two-step PCR approach was used. Reverse transcription and the first PCR step were carried out in a one-step reaction using the Qiagen OneStep RT-PCR kit according to the manufacturer's instructions. As recommended in these instructions, specific nested primers (MWG Biotech) were used as follows: EBI3nested FP: 59-CCTTCATT GCCACTTACAGG-39, EBI3nested RP: 59-TAATCTGTGAGGTCCTGAGC-39; p35nested FP: 59-CATTCTAGACAAGGGCATGC-39, p35nested RP: 59-GTGAT GGGAGAACAGATTCC-39; IL-10nested FP: 59-TCTTACTGACTGGCATGAG G-39; IL-10nested RP: 59-CTTCTACCAGGTAAAACTGG-39; Blimp1nested FP:
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59-CGTGAAGTTTCAAGGACTGG-39; Blimp1nested RP: 59-GTGGTGGAAC TCCTCTCTGG-39. For validation of sorting, b-actin primers were added to the reaction mixture. After this first reaction, an aliquot of the PCR product was loaded on an agarose gel, and only b-actin positive samples were considered to further analysis. A 100-fold dilution of the PCR product was subsequently used as template for the second PCR reaction using the primers described in the section: analysis of mRNA expression by B and plasma cells. Amplification of the respective transcript was verified on an agarose gel. Histology. For immunostaining, 1-to 2-mm sections of formalin-fixed, paraffinembedded tissue were cut, deparaffinized and subjected to a heat-induced epitope retrieval step. Slides were rinsed in cool running water and washed in Tris-buffered saline (pH 7.4) before incubation with primary antibodies against CD3 (cat number N1580, Dako, Glostrup, Denmark, dilution 1:10), and F4/80 (clone BM8, eBioscience, dilution 1:50) for 30 min, followed by biotinylated donkey anti-rat or donkey antirabbit (cat. numbers 712-065-153 and 711-065-152, Dianova, Hamburg, Germany) secondary antibodies. The streptavidin-AP kit (cat. number K5005, Dako) was used for detection. As negative control, primary antibody was omitted. Detection of serum antibodies by ELISA. To quantify Salmonella-specific or NP-OVA-specific antibodies, diluted sera were incubated on 96-well plates coated with 5 3 10 6 heat-killed S. typhimurium per well or 50 mg ml 21 NP (15) 
Validation of chimaeras. B
Ebi3 2/2 and corresponding B WT chimaeras were used as an example to demonstrate the validity of the chimaera system, that is, that the deficiency in the gene of interest is restricted to B cells, and complete in that compartment in B X 2/2 mice. To this end, B cells, CD11b 1 cells and CD4 1 T cells were purified from B Ebi3 2/2 and corresponding B WT chimaeras. Briefly, splenocytes from B Ebi3 2/2 and B WT mice were subjected to CD19 positive selection using magnetic cell sorting. The CD19 1 fraction was subsequently stained for B220 (clone RA3-6B2), CD11b (clone M1/70), CD11c (clone N418), CD4 (clone GK1.5), and CD8 (clone 53.6.72), and FACS-sorted for B220 
CD11b
2 cells, and CD11b
CD4
2 cells, resulting in . 97-98% pure CD4 1 T cells and CD11b 1 cells, respectively. All sorted populations as well as the remaining non-T/B/CD11b 1 cells (denoted as non-T, B, M cells) were lysed and genomic DNA was extracted using the DNeasy Blood & Tissue Kit (Qiagen), according to the manufacturer's instructions. The amounts of genomic DNA present in these samples were equilibrated by real time PCR using the Mog gene as standard with the primer pair: forward 59-AGGAAGGGACATGCAGCCGGA-39; reverse 59-CTGC ATAGCTGCATGACAACTG-39. Wild-type Ebi3 gene was then amplified by conventional PCR with the following primers: forward 59-AACCTCAGGCCA GGCAGT-39; reverse 59-TTCCGTAGGCCATGTAGGAC-39, in order to test for the presence of the wild-type Ebi3 allele in the different cell fractions. Additional reagents. Antibodies used in this study also included anti-Ly6C (clone AL21, cat number 557359, BD Pharmingen), anti-IFN-c (clone XMG1.2, BD Pharmingen), anti-CD154 (cat number 130-092-105, Miltenyi Biotech), anti-CD62L (MEL14, in house). Statistics. Statistical analysis was performed using GraphPad Prism (version 5.02 for Windows, GraphPad Software, USA). EAE data distribution did not differ from normal distribution, as evaluated using Kolmogorov-Smirnov test. Equality of variances between groups was assessed before analyses by ANOVA or t-test. Groups were compared using ANOVA, two-tailed t-test, or Wilcoxon test, as indicated in figure legends. The t-tests were modified using Welch's correction in case of unequal variance. One-way and two-way ANOVA were followed by Bonferroni post-test. No samples were excluded from analysis. Statistical analysis of the gene array data are described in the section gene array hybridization and data analysis. 
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Extended Data Figure 1 | Gene array analysis and IL-35 secretion by B cells activated
in vitro. a, EAE was induced in B
Tlr2 2/2 (squares), B Tlr4 2/2 (triangles) and B WT (circles) mice (see Fig. 1 ). Animals showing a body weight loss .20% and/or sustained front leg impairment were killed in accordance with ethical regulations. Survival curves were compared using Wilcoxon test. b, In the top panels, splenic B cells from C57BL/6 mice were stimulated with lipopolysaccharides (LPS), peptidoglycan (PGN) or CpG DNA oligonucleotides for 72 h, as indicated, and IL-10 concentrations in supernatants were determined by Bio-Plex. Results from stimulated cells were compared to unstimulated B cells (RPMI) using one-way ANOVA followed by Bonferroni post-test (***P , 0.001; **P , 0.01; *P , 0.05; mean 6 s.e.m.); in the bottom panels, splenic B cells were simultaneously activated with anti-CD40 (clone FGK-45; in indicated amounts) and LPS (2 mg ml 21 ), PGN (2 mg ml 21 ) or CpG (2 mg ml 21 ). Supernatants were collected after 72 h and analysed for IL-10 content by Bio-Plex. Data shown are pooled from three independent experiments (mean 6 s.e.m.). Results from B cells stimulated with LPS, CpG or PGN alone were compared to B cells co-stimulated with anti-CD40 using one-way ANOVA followed by Bonferroni post-test (***P , 0.001; **P , 0.01; *P , 0.05). c, Affymetrix MG 430 2.0 whole genome arrays were performed in quadruplicates for naive B cells, B cells activated by TLR4 for 24 h and 72 h, and B cells activated by TLR4 plus CD40 for 24 h and 72 h (20 arrays in total). To obtain genes significantly regulated upon stimulation with LPS, the expression profiles of naive B cells, B cells activated with LPS for 24 h, and B cells activated with LPS for 72 h were compared to each other, generating three lists of differentially expressed Affymetrix IDs (referred to as genes in this figure) , whose union provided a set of n 5 9,703 Affymetrix IDs differentially expressed during LPS activation. A similar analysis yielded a set of n 5 10,456 Affymetrix IDs differentially expressed during LPS plus anti-CD40 activation. The union of these two sets was computed to obtain the list of Affymetrix IDs modulated during B-cell stimulation with LPS or LPS plus anti-CD40 (n 5 12,933). To focus on genes differentially expressed between B cells activated with LPS or LPS plus anti-CD40, the expression profiles of B cells activated with LPS or LPS plus anti-CD40 for 24 h were compared to each other. A similar analysis was done for B cells activated for 72 h. The intersection of these two sets provided the list of Affymetrix IDs differentially expressed between LPS-activated and LPSactivated plus anti-CD40-activated B cells at both 24 h and 72 h (this was done to identify the Affymetrix IDs with long-term differential expression) (n 5 436). The intersection of the set n 5 12,933 with the set n 5 436 gave a list of 417 Affymetrix IDs, which was further filtered on Gene Ontology to extract the Affymetrix IDs corresponding to secreted factors, yielding a final list of 7 genes. d, Signal intensities of p35, Ebi3 and p40 mRNA expression were calculated using the values of the Affymetrix arrays. Data show mean 6 s.e.m. e, f, Splenic murine B cells were stimulated with LPS (1 mg ml 21 ), PGN (10 mg ml 21 ), CpG ODN 1826 (1 mg ml 21 ), and anti-CD40 (clone FGK-45; 10 mg ml 21 ), alone or in combination, as indicated, for 24 h or 72 h. p35 (e) and Ebi3 (f) mRNA expression was then quantified by real-time PCR. Data compile three independent experiments (mean 6 s.e.m.). For statistical analysis, oneway ANOVA test followed by Bonferroni post-test was performed comparing each activated B-cell sample to naive B cells (***P , 0.001; **P , 0.01; mean 6 s.e.m.). g-i, Splenic murine B cells were stimulated for 72 h with anti-IgM (F(ab9)2 goat anti-mouse IgM; Jackson ImmunoResearch; 5 mg ml (black diamonds, n 5 5) and corresponding B WT mice (white triangles, n 5 4). Data show clinical EAE scores (mean 6 s.e.m.) from two independent experiments. Cumulative disease scores were compared using two-tailed unpaired t-test. b, EAE was induced in B p28 2/2 (grey squares; n 5 10) and corresponding B WT mice (dark grey circles, n 5 10). Splenocytes were collected from mice on day 28 after EAE induction, and re-stimulated individually for 48 h with MOG . Supernatants were analysed by ELISA to determine concentrations of IFN-c (middle) and . Data (mean 6 s.e.m.) are pooled from two independent experiments. c, EAE was induced in B p35 2/2 (triangles), B Ebi3 2/2 (diamonds), B p40 2/2 (squares), and B WT (circles) mice (see Fig. 2 ). Animals showing a body weight loss . 20% and/or sustained front leg impairment were killed in accordance with ethical regulations. Survival curves were compared using Wilcoxon test. d, Splenocytes were collected from B , and B WT mice on day 28 after EAE induction (see Fig. 2a ), and pooled before re-stimulation for 48 h with MOG . Culture supernatants were analysed by ELISA to determine concentrations of IFN-c (left) and . Data show representative results from two independent experiments. Statistical analysis was performed using the two-way-ANOVA test followed by a Bonferroni post-test (*P , 0.05, **P , 0.01; ***P , 0.001; mean 6 s.e.m. (n 5 6) and corresponding B WT mice (n 5 6). Mice were killed on day 10 after immunization and splenic B cells were analysed by flow cytometry for surface expression of antigen-presenting molecules (MHC II), co-stimulatory molecules (CD80, CD86), and activation markers (CD44, CD69). MFI, mean fluorescence intensity. Data (mean 6 s.e.m.) are pooled from two independent experiments. Results were compared using two-tailed unpaired t-test with Welch's correction in case of inequal variances. b, Representative histogram plots showing expression of these molecules on wild-type and p35-deficient B cells. Dead cells were excluded using propidium iodide. c, EAE was induced in , B p40 2/2 and corresponding B WT mice were infected intravenously with virulent Salmonella strain SL1344 (100 c.f.u.). Bacterial loads in spleens (top) and livers (bottom) were determined on day 6 post-infection (p.i). Data (mean 6 s.e.m.) are pooled from two independent experiments. Numbers of mice analysed: B p35 2/2 (n 5 6) and corresponding B WT mice (n 5 8), B Ebi3 2/2 (n 5 5) and corresponding B WT mice (n 5 5), B p40 2/2 (n 5 6) and corresponding control B WT mice (n 5 5). Data were analysed with two-tailed unpaired t-test. P values . 0.05 are indicated by ns. b, Top shows liver histochemistry of total infiltrating cells (haematoxylin and eosin; H&E), T cells (CD3), and macrophages (F4/80) at day 6 p.i.; bottom, numbers of inflammatory foci per liver section on day 6 p.i. Data (mean 6 s.e.m.) are pooled from two independent experiments. Numbers of mice analysed: B p35 2/2 (n 5 6) and corresponding B WT mice (n 5 8), B Ebi3 2/2 (n 5 7) and corresponding B WT mice (n 5 5), B p40 2/2 (n 5 7) and corresponding B WT mice (n 5 8). Data were compared using two-tailed unpaired t-test with Welch's correction in case of inequal variances. P values . 0.05 are indicated by ns. c, B p28 2/2 (n 5 6) and corresponding B WT (n 5 6) mice were infected intravenously with attenuated Salmonella (strain SL7207). On day 21 p.i. bone marrow (BM) cells were isolated from individual mice, and re-stimulated for 6 h with heat-killed Salmonella before staining for surface CD4, and intracellular CD40L or IFN-c. (top Ebi3 2/2 (n 5 10) and corresponding B WT mice (n 5 10), B p40 2/2 (n 5 15) and corresponding B WT mice (n 5 9), B p28 2/2 (n 5 6) and corresponding B WT mice (n 5 6). , B p40 2/2 and their corresponding B WT mice were infected with attenuated Salmonella (strain SL7207). Relative titres of Salmonella-reactive IgM and IgG in serum were determined by ELISA. Data (mean 6 s.e.m.) are pooled from three independent experiments. Numbers in brackets indicate the numbers of mice analysed for each measurement. b, B p35 2/2 (n 5 17) and corresponding B WT mice (n 5 16) were immunized with 200 mg NP-OVA in alum intraperitoneally. Relative titres of NP(15)-BSA-reactive antibodies in serum were determined by ELISA. Data (mean 6 s.e.m.) are pooled from three independent experiments. Results were compared using two-tailed unpaired t-test. P values .0.05 are indicated by ns. c, Mice were infected with 100 c.f.u. of virulent Salmonella. Upper left shows survival curves of B Cd40 2/2 (n 5 9) and corresponding B WT mice (n 5 16). Data are pooled from two independent experiments. Survival curves were compared using Wilcoxon test. Upper right, numbers of inflammatory foci per liver section were determined on day 5 p.i. Lower panel, bacterial loads in liver (left) and spleen (right) were determined on day 5 p.i. Data (mean 6 s.e.m.) are pooled from two independent experiments. Numbers of mice analysed: B Cd40 2/2 (n 5 12), and corresponding B WT mice (n 5 13). Results were analysed using two-tailed unpaired t-test with Welch's correction. 
LETTER RESEARCH
RESEARCH LETTER
CD138
2 B cells and CD138 hi plasma cells in total splenocytes on day 3 after challenge (left plots), after magnetic isolation (middle plots), and after FACS isolation (right plots). b, Single CD138 hi cells were isolated on indicated days, and analysed by single cell-PCR using a mix of primers for b-actin, Il10, p35 and Ebi3. Only cells giving a positive signal for b-actin were included in the calculations shown. Data show frequencies of CD138 hi cells that gave a positive signal for Il10, both p35 and Ebi3, or Il10 and p35 and Ebi3. Numbers of cells tested: day 1 (181 cells; 86% positive for b-actin), day 3 (156 cells; 79% positive for b-actin) and day 8 (163 cells; 97% positive for b-actin). Cells were obtained from two independent experiments. c, d, CD138 hi plasma cells and CD19
1
CD138
2 B cells were enriched by magnetic isolation (as described in a) from spleen of C57BL/6 mice on day 3 after infection with attenuated Salmonella (SL7207; 10 7 c.f.u. ) were determined by ELISPOT assay. A compilation of two independent experiments is shown (mean 6 s.e.m.). c, Blimp1, Irf4, Pax5, Il10, Ebi3 and p35 mRNA expression was quantified by real-time PCR in these populations. Naive splenic B cells (naive CD19 1 ) were isolated from unchallenged C57BL/6 mice by magnetic selection. Data show the compilation of three independent experiments (mean 6 s.e.m.). d, Plasma cells accumulate in splenic red pulp aggregates adjacent to white pulp areas on day 3 after Salmonella infection. C57BL/6 mice were infected intravenously with attenuated Salmonella (SL7207; 10 7 c.f.u.), and spleens were harvested 3 days later. Spleen sections (7 mm) were stained with: top panels: anti-Ig-k (clone 187.1; green), anti-Igl (clone SL136; green), anti-CD90 (clone T24; red) and anti-CD22 (clone OX-97; blue); middle panels: anti-Ig-k (clone 187.1; red), anti-Igl (clone SL136; red), anti-CD11b (clone M1/70; green), and anti-CD22 (clone OX-97; blue); bottom panels: anti-Ig-k (clone 187.1; red), anti-Igl (clone SL136; red), anti-CD169 (clone MOMA-1; green), and anti-CD22 (clone OX-97; blue). . In contrast, all other haematopoietic lineages developed from both X 2/2 and JHT BM cells. As the JHT and X 2/2 BM cells were injected in a ratio 80:20, most haematopoietic cells other than B cells carried a wild-type genotype for X in B X 2/2 mice. Right, the corresponding control B WT mice were obtained by reconstituting lethally irradiated recipient mice with a mixture of BM cells from WT C57BL/6 mice (80%) and from X 2/2 mice (20% 
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2 cells (indicated as Non-T,B,M). Genomic DNA samples from tail biopsies of C57BL/6 and Ebi3 2/2 mice were used as controls. The amounts of genomic DNA present in each sample were equilibrated using the Mog gene as standard. Using equilibrated samples, the wild-type Ebi3 allele was detected by PCR in all DNA preparations except for B cells from B Ebi3 2/2 mice, and the tail biopsy from , B p40 2/2 and corresponding B WT controls were killed after reconstitution. Data show the percentage of CD19 1 B cells in spleen, as determined by flow cytometry. Data are pooled from 2-3 independent experiments. Data (mean 6 s.e.m.) include B p35 2/2 (n 5 6) and corresponding B WT mice (n 5 7), B Ebi3 2/2 (n 5 7) and corresponding B WT mice (n 5 9), B p40 2/2 (n 5 7) and corresponding B WT mice (n 5 7 RESEARCH LETTER
